Creso Pharma’s (ASX:CPH) goal is to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Our Latest Articles on Creso Pharma
|Article||02-Dec-2020||What’s Happening to the CPH Share Price?|
|Article||13-Oct-2020||Canopy Growth Founder Joins a Refreshed, Re-Set and Re-Funded CPH|
|Article||24-Mar-2020||Creso’s New Immunity Boosting CBD Hemp Teas Set for Release|
|Article||11-Mar-2020||CPH Secures Two Execs from the World’s Largest Cannabis Company|
|Article||04-Mar-2020||Scandinavian Sales Agreement Expands Creso Pharma’s European Footprint|
|Article||11-Feb-2020||Creso on a Roll: New Hemp Plant Product for Equines and Large Animals Set for Release|
|Article||06-Feb-2020||CPH Set to Expand cannaQIX® Product Line After Major Technological Breakthrough|
|Article||28-Jan-2020||CPH’s cannaQIX® Products Have Now Exceeded the 2.5 million Lozenges Sold Milestone|
|Article||21-Jan-2020||CPH Delivers Over 3 Million Anibidiol Doses to Europe's Dogs|
|Article||09-Dec-2019||CPH Kick Start African Launch - $300k Order Values Confirmed|
|Article||03-Dec-2019||Can New Cannabis Products Launch Creso Pharma Higher in 2020?|
What’s Happening to the CPH Share Price?
Dec 2, 2020
Over recent days, Creso Pharma (ASX: CPH) appears to have gained some significant momentum. Momentum includes three new purchase orders for Creso Pharma’s anibidiol® line of animal health products were signed today, to a value of $A$414,000.
Canada Legalises Cannabis as CPH Moves Front and Centre With a 100% Owned Canadian Growing Facility
Oct 18, 2018
CPH Gets Green Light to Distribute its Innovative CBD Based Nutraceutical Products in the UK
Jan 18, 2018
CPH Seal Swiss Pharma Deal: Setting the Cornerstone for Global Commercialisation of cannaQIX
Dec 4, 2017